Menicon Co., Ltd. (MNNLF)
OTCMKTS
· Delayed Price · Currency is USD
7.10
-2.60 (-26.80%)
May 23, 2025, 4:00 PM EDT
Menicon Revenue
In the fiscal year ending March 31, 2025, Menicon had annual revenue of 121.49B JPY with 4.56% growth. Menicon had revenue of 29.98B in the quarter ending March 31, 2025, with 4.14% growth.
Revenue
121.49B JPY
Revenue Growth
+4.56%
P/S Ratio
0.70
Revenue / Employee
28.78M JPY
Employees
4,221
Market Cap
567.48M USD
Revenue Chart
* This company reports financials in JPY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 121.49B | 5.30B | 4.56% |
Mar 31, 2024 | 116.19B | 6.00B | 5.44% |
Mar 31, 2023 | 110.19B | 10.02B | 10.00% |
Mar 31, 2022 | 100.17B | 13.96B | 16.20% |
Mar 31, 2021 | 86.21B | 1.69B | 2.00% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
American Oncology Network | 1.76B |